Richard Bernstein Advisors LLC Biogen Inc. Transaction History

Richard Bernstein Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $495,982 - $637,410	-2,215 Reduced 39.6%	3,379 $811,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $121,685 - $158,691	430 Added 8.33%	5,594 $1.58 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $605,061 - $910,768	-2,561 Reduced 33.15%	5,164 $1.26 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $911,132 - $1.16 Million	-3,389 Reduced 30.49%	7,725 $2.44 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $3.26 Million - $4.27 Million	11,114 New	11,114 $3.93 Million

1,023

126M

2.32M

4.26M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $18.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Richard Bernstein Advisors LLC with notifications on news.